BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
50.65
-0.85 (-1.65%)
At close: Sep 24, 2025, 3:59 PM
50.13
-1.03%
After-hours: Sep 24, 2025, 06:38 PM EDT
-1.65% (1D)
| Bid | 50.12 |
| Market Cap | 9.68B |
| Revenue (ttm) | 235.81M |
| Net Income (ttm) | -776.41M |
| EPS (ttm) | -4.13 |
| PE Ratio (ttm) | -12.26 |
| Forward PE | -28.32 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 52 |
| Volume | 1,532,216 |
| Avg. Volume (20D) | 2,757,963 |
| Open | 51.26 |
| Previous Close | 51.50 |
| Day's Range | 50.25 - 51.85 |
| 52-Week Range | 21.72 - 54.60 |
| Beta | 1.25 |
| Ex-Dividend Date | n/a |
About BBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBridgeBio Pharma Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-8.94%
BridgeBio Pharma shares are trading lower after th...
Unlock content with
Pro Subscription
1 month ago
+3.06%
BridgeBio Pharma shares are trading lower after the company reported worse-than-expected Q2 EPS results.
